GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Eckert & Ziegler SE (CHIX:EUZd) » Definitions » ROE % Adjusted to Book Value

Eckert & Ziegler SE (CHIX:EUZD) ROE % Adjusted to Book Value : 2.41% (As of Sep. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Eckert & Ziegler SE ROE % Adjusted to Book Value?

Eckert & Ziegler SE's ROE % for the quarter that ended in Sep. 2024 was 8.63%. Eckert & Ziegler SE's PB Ratio for the quarter that ended in Sep. 2024 was 3.58. Eckert & Ziegler SE's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was 2.41%.


Eckert & Ziegler SE ROE % Adjusted to Book Value Historical Data

The historical data trend for Eckert & Ziegler SE's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eckert & Ziegler SE ROE % Adjusted to Book Value Chart

Eckert & Ziegler SE Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.63 2.63 2.20 3.63 4.40

Eckert & Ziegler SE Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.24 3.92 4.98 4.39 2.41

Competitive Comparison of Eckert & Ziegler SE's ROE % Adjusted to Book Value

For the Medical Devices subindustry, Eckert & Ziegler SE's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eckert & Ziegler SE's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Eckert & Ziegler SE's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Eckert & Ziegler SE's ROE % Adjusted to Book Value falls into.



Eckert & Ziegler SE ROE % Adjusted to Book Value Calculation

Eckert & Ziegler SE's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=12.11% / 2.75
=4.40%

Eckert & Ziegler SE's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=8.63% / 3.58
=2.41%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Eckert & Ziegler SE ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Eckert & Ziegler SE's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Eckert & Ziegler SE Business Description

Traded in Other Exchanges
Address
Robert-Rossle-Street 10, Berlin, BB, DEU, 13125
Eckert & Ziegler SE is a provider of isotope technology for medical, scientific, and industrial use. It is predominantly engaged in the business of cancer therapy, industrial radiometry, and nuclear medical imaging. The company's segments are Medical, Isotope Products, and Other. The Isotope Products segment which generates key revenue, manufactures and distributes standards and radiation sources for medical and industrial purposes. The Medical segment provides pharmaceutical-quality radioactive ingredients and markets products for the treatment and diagnosis of cancers. The Other segment comprises the items of the holding company. Geographically, the company generates a majority of its revenue from Europe and the rest from North America, Asia/Pacific, and other regions.

Eckert & Ziegler SE Headlines

No Headlines